Victory Capital Management
DTIL icon

Victory Capital Management’s Precision BioSciences DTIL Stock Holding History

Victory Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-403
Closed -$19K – 2718
2022
Q2 		$19K Buy
+403
New +$23.7K ﹤0.01% 2621
2020
Q3 		– Sell
-6,518
Closed -$1.63M – 2508
2020
Q2 		$1.63M Sell
6,518
-32,597
-83% -$7.14M ﹤0.01% 1506
2020
Q1 		$7.08M Buy
39,115
+18,684
+91% +$4.89M 0.01% 1175
2019
Q4 		$8.51M Buy
20,431
+11,225
+122% +$3.53M 0.01% 1055
2019
Q3 		$2.32M Buy
9,206
+4,645
+102% +$1.51M ﹤0.01% 1396
2019
Q2 		$1.81M Buy
4,561
+3,768
+475% +$1.52M ﹤0.01% 1164
2019
Q1 		$427K Buy
+793
New +$421K ﹤0.01% 1349

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Victory Capital Management's DTIL Position: Q3 2022 in Review

Victory Capital Management sold out of Precision BioSciences (DTIL) in Q3 2022, closing a stake of 403 shares — an estimated $19K sold.

Victory Capital Management first reported a position in DTIL in Q1 2019 and held it in 7 quarters. The position peaked at $8.51M in Q4 2019. 102 funds tracked by Wall St. Rank hold DTIL as of Q3 2022.

  • Victory Capital Management reported no remaining Precision BioSciences position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 403 Precision BioSciences shares in Q3 2022, an estimated $19K.
  • Victory Capital Management first reported a position in Precision BioSciences in Q1 2019 and held it in 7 quarters.
  • Victory Capital Management's Precision BioSciences position peaked at $8.51M in Q4 2019.
  • 102 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.